Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial
Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLiuchow, China was added to the locations list and Liuzhou, China was removed. The page revision was updated to v3.3.2.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded a new site entry: Tainan, Taiwan, 704, and removed the entry labeled Tainan City, Taiwan, 704.SummaryDifference0.2%

- Check34 days agoChange DetectedNo additions or deletions were detected; the page content remains focused on study details, eligibility criteria, and locations.SummaryDifference0.2%

- Check63 days agoChange DetectedThe page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.SummaryDifference2%

- Check70 days agoChange Detected- Page version updates to v3.1.0. - Several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) are removed, indicating a narrowing of scope or rebranding rather than the addition of new topics.SummaryDifference0.3%

- Check85 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2. Removed the 'Back to Top' element.SummaryDifference0.1%

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.